Director, Scientific & Analysis

The Director, Scientific & Competitive Analysis leads the Oncology Business Unit's competitive intelligence function and team, delivering integrated insights through primary and secondary intelligence sources. The role is accountable for the function’s strategy, operating model, governance, priorities, and quality standards, and for translating scientific, clinical, regulatory, commercial, and market developments into actionable insights that inform brand strategy, clinical development, business development evaluations, launch planning, and disease area strategy.

As the leader of Scientific & Competitive Analysis, you will establish the strategic direction and methodologies for competitive intelligence across multiple brands, disease areas, pipeline assets, launches, and markets, and ensure the organization maintains a comprehensive understanding of the evolving competitive landscape. The Scientific & Competitive Analysis team operates as an embedded strategic partner to brand teams throughout the product lifecycle.

Working closely with brand, portfolio, commercial, medical, and executive leaders, the team proactively identifies competitive risks, opportunities, and emerging market signals, translating them into business implications and strategic recommendations. Proactively ensure competitive intelligence is incorporated into brand, launch, and portfolio decisions by identifying emerging competitive risks and opportunities, assessing business implications, and providing actionable recommendations.

Lead and develop a high-performing Scientific & Competitive Analysis team, establishing priorities, deploying team and budget resources, and building capabilities and ways of working aligned to Oncology Business Unit objectives. Drive the team to act as embedded strategic partners to brand teams, aligning competitive intelligence activities to business priorities and providing ongoing counsel that informs brand strategy, launch planning, lifecycle management, and portfolio decisions.

Serve as the Oncology Business Unit’s competitive early warning system by anticipating market shifts, competitor actions, emerging opportunities, and strategic risks; elevate significant developments and initiate coordinated response planning and actionable recommendations. Develop, prioritize, and execute intelligence plans across brands, disease areas, pipeline assets, launches, and markets, ensuring ongoing monitoring and assessment of competitive, scientific, clinical, regulatory, and market developments.

Deliver forward-looking competitive assessments, including business implications, potential scenarios, and actionable recommendations to inform clinical development, commercialization, and portfolio decisions. Lead competitive scenario planning and response planning activities to prepare the organization for key market events and competitive disruptions. Serve as a strategic partner to Commercial, Medical, Market Access, NPP, BD, R&D, and other stakeholders, providing intelligence that supports growth strategies, pipeline decisions, and business development evaluations.

Collaborate with Market Research, Forecasting, and Analytics teams to deliver integrated insights and a comprehensive view of market dynamics. Provide regular competitive landscape updates and recommendations to leadership and cross-functional governance teams to inform investment, development, launch, business development, and portfolio decisions. Lead the planning and execution of competitive intelligence activities at major scientific and industry conferences and ensure timely dissemination of insights to global and regional stakeholders.

Manage and deploy external competitive intelligence…